More than 30 sites are known to be a substrate of GSK-3β, which suggests that the insulin or insulin-like growth factor 1 (IGF-1) may contribute to AD pathogenesis and NFT toxicity [85,93]. The gene discussed is INS; the disease is Alzheimer disease.